AMR Shares How Cognizant® Shared Investigator Platform Has Transformed Their Clinical Trials

Given the impact of the pandemic and the advent of technologies like AI and remote collaboration, life sciences organizations worldwide are reevaluating their approaches to conducting clinical trials.

Cognizant®'s Shared Investigator Platform (SIP) represents a novel strategy for optimizing clinical trials. As the first open, SaaS-based clinical ecosystem in the industry, Cognizant SIP seamlessly connects sponsors, research sites, and technology providers, regardless of their location, all through a single platform with a unified sign-in.

Numerous prominent life sciences companies have embraced SIP, committing to a shared vision of standardized workflows, training, and documentation. Both sponsors and research sites have reported enhanced efficiency and quicker initiation of studies. The outcome? Accelerated time-to-market for new therapies and increased focus on patient care.

Watch the full video below as Missy MacPhail, Executive Director of Business Development at Alliance for Multispecialty Research, LLC shares her experience with SIP and how it's benefited AMR.